DKK1 and pachyonychia congenita: The decline of DKK-1 levels in bone metastases is interlinked with the osteoblastic activity of Wnt and supports a model in which DKK-1 is a molecular switch that transitions the phenotype of PC bone lesions from osteolytic to osteoblastic.